Related Experiment Videos
Selective nephroangiography in the dog causing renal platelet aggregation and irregular nephrographic phase
Acta Radiologica: Diagnosis
|September 1, 1985
Summary
Large doses of ionic contrast media (metrizoate) can cause kidney damage in dogs by inducing platelet and fibrinogen accumulation, leading to thrombi and patchy contrast retention. Smaller doses did not produce these adverse effects.
Area of Science:
- Nephrology
- Radiology
- Veterinary Medicine
Background:
- Ionic contrast media are widely used in diagnostic imaging.
- Potential adverse effects of contrast media on renal function require thorough investigation.
- Understanding the mechanisms of contrast-induced nephropathy is crucial for patient safety.
Purpose of the Study:
- To investigate the effects of selective renal artery injections of metrizoate on canine kidneys.
- To elucidate the pathogenetic mechanisms underlying contrast medium-induced renal injury.
- To determine the dose-dependent effects of metrizoate on renal imaging and histology.
Main Methods:
- Selective renal artery injections of varying doses of metrizoate in dogs.
- Assessment of nephrographic phase during angiography.
- Evaluation of platelet and fibrinogen accumulation in renal tissue.
- Microscopic examination for thrombi and tubular damage.
Main Results:
- Large doses of metrizoate induced an irregular nephrographic phase ('patchy contrast medium retention') in 14/16 dogs.
- Associated findings included transient platelet/fibrinogen accumulation and thrombi in afferent arterioles and glomerular capillaries.
- Tubular damage was observed in 4/6 dogs examined 48 hours post-injection.
- Small doses of metrizoate resulted in a homogeneous nephrographic phase without thrombi.
Conclusions:
- Contrast medium-induced endothelial damage may be a key mechanism in developing thrombi and patchy contrast retention.
- Dose-dependent effects of ionic contrast media on renal vasculature and parenchyma are significant.
- These findings highlight potential risks associated with high-dose contrast administration in renal arteries.